Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
Sarah Howlett, Thomas J. Carter, Heather M. Shaw, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2256-2266
Open Access | Times Cited: 98
Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications
Raj Kumar Chinnadurai, Nazam Khan, Gautam Kumar Meghwanshi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114996-114996
Open Access | Times Cited: 47
Bispecific antibodies: advancing precision oncology
M. Zurita Herrera, G. Pretelli, Jayesh Desai, et al.
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 893-919
Open Access | Times Cited: 15
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma
Robin Reschke, Alexander Enk, Jessica C. Hassel
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1046-1046
Open Access | Times Cited: 6
Targeted therapy in ophthalmic oncology: The current status
Mrittika Sen, Hakan Demirci, Santosh G Honavar
Asia-Pacific Journal of Ophthalmology (2024) Vol. 13, Iss. 2, pp. 100062-100062
Open Access | Times Cited: 5
Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications
Zahra Sadat Dastgheib, Samira Sadat Abolmaali, Ghazal Farahavar, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35655-e35655
Open Access | Times Cited: 5
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 5
Genetic and Epigenetic Features of Uveal Melanoma—An Overview and Clinical Implications
Daria Pašalić, Tamara Nikuševa-Martić, Ankica Sekovanić, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12807-12807
Open Access | Times Cited: 11
Acral melanoma: new insights into the immune and genomic landscape
Larissa Anastácio da Costa Carvalho, Flavia C. Aguiar, Keiran S.M. Smalley, et al.
Neoplasia (2023) Vol. 46, pp. 100947-100947
Open Access | Times Cited: 11
Characterizing uveal melanoma patients with peritoneal metastases: a retrospective single-center analysis
Stanislav Rosnev, Caroline Anna Peuker, Iris Piwonski, et al.
European Journal of Cancer (2025) Vol. 218, pp. 115280-115280
Open Access
T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H
Volker Lennerz, Christoph Doppler, Martina Fatho, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bispezifische Antikörper in der Therapie hämatologischer Neoplasien und solider Tumoren
Xiang Zhou, Johannes M. Waldschmidt, Hermann Einsele
Deleted Journal (2025)
Open Access
Unravelling the Molecular Pathways of Feline Diffuse Iris Melanoma Progression
David Kayes, B. Blacklock, Robert I. McGeachan, et al.
Research Square (Research Square) (2025)
Closed Access
Application of new approach methodologies for nonclinical safety assessment of drug candidates
Mario Beilmann, Karissa Adkins, Harrie C. M. Boonen, et al.
Nature Reviews Drug Discovery (2025)
Closed Access
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
Alessandra Loda, Francesco Semeraro, Silvia Parolini, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189104-189104
Open Access | Times Cited: 2
GZ17-6.02 kills PDX isolates of uveal melanoma
Laurence Booth, Jane L. Roberts, Ivan Spasojević, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 328-344
Open Access | Times Cited: 2
A centrosome-related gene signature for predicting the overall survival of uveal melanoma
Xin Yu, Xiaoyu Guo, Wenge Li, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 771-781
Open Access | Times Cited: 1
What matters most to people with metastatic uveal melanoma? A qualitative study to inform future measurement of health-related quality of life
Carrie‐Anne Ng, Tim Luckett, Brendan Mulhern, et al.
Melanoma Research (2024)
Open Access | Times Cited: 1
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy
Andrew Knight, Jason J. Luke
Current Oncology Reports (2024) Vol. 26, Iss. 7, pp. 826-839
Closed Access | Times Cited: 1
Exploring the potential of structure-based deep learning approaches for T cell receptor design
Helder Veras Ribeiro Filho, Gabriel Ernesto Jara, João Victor da Silva Guerra, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 9, pp. e1012489-e1012489
Open Access | Times Cited: 1
Unlocking Intracellular Oncology Targets: The Unique Role of Antibody-Based T-Cell Receptor Mimic (TCRm) Therapeutics in T-Cell Engagers (TCEs) and Antibody-Drug Conjugates (ADCs)
Jeffrey J. Molldrem, Dongxing Zha
Cancers (2024) Vol. 16, Iss. 22, pp. 3776-3776
Open Access | Times Cited: 1
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Mengdi Ma, Yongliang Zhang, Kanyi Pu, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 1
Current Advances in Bispecific T Cell–Engaging Therapies
Emmanuel Owusu Ansah, Bernard Ansong Nyarko
(2024)
Open Access | Times Cited: 1
Recent Advancements in Cell-Based Therapies in Melanoma
George Nassief, Angela Anaeme, Karen Moussa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9848-9848
Open Access | Times Cited: 1
Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma
Helena Robinson, Antonio Eleuteri, Joseph J. Sacco, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2610-2610
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top